Editorial: Cyclic Nucleotide Phosphodiesterases (PDEs) in Immune Regulation and Inflammation
Stefan Brocke1, Paul M Epstein2, Robert Nelson3
1Department of Immunology, UConn Health, Farmington, CT, United States.
Frontiers in Pharmacology
|July 25, 2022
Abstract
No abstract available in PubMed .
Keywords:
3′,5′-cyclic nucleotide phosphodiesterasecell signalinginflammationsmall molecule inhibitortherapeutic targets

